Glucose Health (OTCMKTS:GLUC) Stock Price Down 9.5% – Here’s Why

Glucose Health, Inc. (OTCMKTS:GLUC)’s share price dropped 9.5% during trading on Wednesday . The company traded as low as $0.2450 and last traded at $0.25. Approximately 30,000 shares were traded during trading, an increase of 8% from the average daily volume of 27,759 shares. The stock had previously closed at $0.2763.

Key Glucose Health News

Here are the key news stories impacting Glucose Health this week:

• Positive Sentiment: Medscape analysis argues for wider use of continuous glucose monitoring during pregnancy, which signals clinical acceptance and a broader addressable market for CGM-related products and services. The Case for Continuous Glucose Monitoring in Pregnancy
• Positive Sentiment: Local and nonprofit education efforts (e.g., VisionCorps webinar) keep diabetes awareness high — potentially supporting longer-term demand for monitoring and digital-care services. Living with diabetes educational webinar
• Neutral Sentiment: Numerous consumer pieces on diet, sweeteners, exercise and blood‑sugar management reflect growing public interest but have unclear near-term impact on GLUC revenue. Representative coverage includes guidance on meal timing and sweeteners. How often should you eat throughout the day for optimal blood sugar levels?
• Neutral Sentiment: Articles on practical steps (10‑minute post-meal walks, food choices) likely support long-term prevention and monitoring markets but don’t imply immediate product adoption or revenue for GLUC. 10-minute walk after meals can improve blood sugar levels
• Negative Sentiment: Huawei added a needle‑free diabetes‑risk monitoring feature to its Watch GT 6 Pro — a direct competitive signal from a large wearable player that could pressure smaller specialists like Glucose Health on market share and pricing. Huawei’s Smartwatch Adds Needle-Free Diabetes Risk Monitoring
• Negative Sentiment: Early-stage treatments showing promise for type 1 diabetes (research coverage) are long-term development risks — if curative therapies progress, they could reduce need for chronic monitoring over many years. The news currently remains preliminary but is a potential negative catalyst. Can Type 1 diabetes be cured? New treatment shows promise at UH

Glucose Health Trading Down 9.5%

The firm has a market capitalization of $5.11 million, a P/E ratio of -8.33 and a beta of 1.27. The stock has a 50 day simple moving average of $0.26 and a 200-day simple moving average of $0.15.

Glucose Health Company Profile

Glucose Health, Inc engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc in November 2014. Glucose Health, Inc was incorporated in 2007 and is based in Bentonville, Arkansas.